These findings suggest that overexpression of both IRS1 and IRS2 emerges as crucial factors in cancer cell migration, warranting a more comprehensive understanding of the precise mechanism by which insulin dysfunction-dependent activated IRS proteins contribute to cancers. The gene discussed is IRS2; the disease is cancer.